Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bismuth subcarbonate is an inorganic compound with the formula (BiO)₂CO₃, containing both oxide and carbonate anions. It occurs naturally as the mineral bismutite and is used primarily for its antacid, astringent, and antidiarrheal properties. Bismuth subcarbonate has been widely employed to treat gastrointestinal disorders such as indigestion, diarrhea, and peptic ulcers. Its mechanism of action involves local protective effects on mucosal surfaces in the gastrointestinal tract due to its astringent properties. Additionally, it is highly radiopaque and used as a filler in radiopaque catheters visible by x-ray; it also finds use in cosmetics and some pharmaceuticals[1][4][5][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on bismuth subcarbonate.